ANEB
ANEB
NASDAQ · Pharmaceuticals

Anebulo Pharmaceuticals Inc

$0.35
-0.04 (-10.30%)
As of Jun 23, 10:10 PM ET ·
Analyst Consensus
Strong Sell
6
Analysts
Moderate
Coverage
Buy 0 0%
Hold 3 50%
Sell 3 50%
Price Target
Analyst Price Target +14,174.7% upside
Low Target $34.23
Average Target $49.99
High Target $60.95
Current Price $0.35
Current
$0.35
Target
$49.99
$34.23 $49.99 avg $60.95
Scenario Analysis
Bear Case
$34.23
9,674.4%
Low target
Base Case
$49.99
+14,174.7%
Avg target
Bull Case
$60.95
+17,304.3%
High target
Risk/Reward
1.8x
Balanced
Price in Context
52-Week High
$3.42
-89.8% from high
52-Week Low
$0.30
+16.8% from low
Target vs 52W High
$49.99
+1,361.7% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 39 79% $1,330.33 +20.2%
RDY
Dr. Reddy's Laboratories
Sell 44 50% +0.0%
JNJ
Johnson & Johnson
Buy 31 68% $299.55 +25.3%
MRK
Merck & Co. Inc.
Buy 36 69% $159.27 +33.2%
PFE
Pfizer Inc.
Hold 36 42% $33.90 +37.1%
BMY
Bristol-Myers Squibb Co
Hold 36 39% $174.50 +214.2%
ZTS
Zoetis Inc
Buy 24 58% $209.87 +173.1%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -34.5%